ArticleTzu chi medical journal

Melatonin combined with sorafenib synergistically inhibit the invasive ability through targeting metastasis-associated protein 2 expression in human renal cancer cells.

Chu-Che Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.